Disease/Infection News

RSS

Study unveils genetic architecture that enables parasite to develop antimalarial drug resistance

The largest genome-wide association study to date of the malaria parasite Plasmodium falciparum unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin. The results could help to improve early detection of emerging artemisinin resistance.

20 Jan 2015

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

It was back in the 1960s that scientists first started to understand that breath could be used to find out different things about diseases and other factors. I’m sure you’re familiar with alcohol breath testing, which was patented back in the ‘50s and has been used since the ‘60s.

19 Jan 2015

UC RUSAL announces opening of new epidemic and microbiological research centre in Guinea

UC RUSAL, a leading global aluminium producer, announces that construction of the "Centre for epidemic and microbiological research and treatment" in the Kindia administrative region of the Republic of Guinea has completed.

19 Jan 2015

Increase in Lassa fever cases could be due to human-to-human transmission, research reveals

One in five cases of Lassa fever - a disease that kills around 5,000 people a year in West Africa - could be due to human-to-human transmission, with a large proportion of these cases caused by 'super-spreaders', according to research published today in the journal PLOS Neglected Tropical Diseases.

16 Jan 2015

Early estimates indicate flu vaccine is providing little protection in US

Each year the Centers for Disease Control and Prevention (CDC) undertake flu vaccine effectiveness studies. Early estimates for the current season indicate that those people (all ages) who had the flu vaccine were only 23% less likely to have to go to the doctor because of flu (influenza).

16 Jan 2015

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets). The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.

16 Jan 2015

Mobile diagnosis device to help reduce unnecessary antibiotics prescribing

New biosensor-based technology could help to reduce the over-prescribing of antibiotics by giving GPs and other frontline healthcare staff an accurate and fast method of identifying the nature of infectious diseases.

15 Jan 2015

Leading microbiologist warns of killer fungi’s increasing threat

A leading microbiologist has warned of the increasing threat that killer fungi poses to humans and the environment.

15 Jan 2015

New computer model could predict responses to disease outbreak

Sometimes the response to the outbreak of a disease can make things worse -- such as when people panic and flee, potentially spreading the disease to new areas. The ability to anticipate when such overreactions might occur could help public health officials take steps to limit the dangers.

15 Jan 2015

NIAID awards contracts to support early-stage human clinical trials of infectious disease treatments

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded contracts to three organizations to support early-stage human clinical trials of investigational infectious disease treatments. The new awards for the Phase I Clinical Trial Units for Therapeutics increases the number of funded organizations under the program from two to three, expanding capacity for conducting early safety testing of novel investigational drugs.

15 Jan 2015

HIV/AIDS survival rates lower in the southern U.S.

The southern U.S. had the nation's lowest five-year survival rate among those diagnosed with HIV or AIDS in 2003-2004, according to new research.

15 Jan 2015

People with iron overload disease are more vulnerable to Vibrio vulnificus infections

Every summer, the news reports on a bacterium called Vibrio vulnificus found in warm saltwater that causes people to get sick, or die, after they eat raw tainted shellfish or when an open wound comes in contact with seawater.

15 Jan 2015

Study suggests that antibiotics may help fight norovirus

Antibiotics aren't supposed to be effective against viruses. But new evidence in mice suggests antibiotics may help fight norovirus, a highly contagious gastrointestinal virus, report scientists at Washington University School of Medicine in St. Louis.

14 Jan 2015

Universal vaccine against flu may be on the horizon, say researchers

The fact that this year's flu shot is not a good match against this year's influenza strain is well known, and has happened before.

14 Jan 2015

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

University Hospitals Case Medical Center has signed an agreement with Advanced Biological Laboratories, an information technology and diagnostic company based in Luxembourg, to join efforts on the designing and validation of an HIV drug resistance and tropism assay based on next-generation sequencing (NGS).

14 Jan 2015

Mayo Clinic expert explains difference between severe sepsis and septic shock

Sepsis can be a dangerous complication of almost any type of infection, including influenza, pneumonia and food poisoning; urinary tract infections; bloodstream infections from wounds; and abdominal infections.

14 Jan 2015

QDREC software may help find effective treatment for schistosomiasis

For decades, scientists around the world have worked to develop a treatment for schistosomiasis, a debilitating water-born parasite that affects more than 200 million people worldwide. To aid this research, Rahul Singh, professor of computer science at San Francisco State University, has developed software that solves the key challenge of quantitatively assessing the impact of a drug on the parasite.

14 Jan 2015

Cold atmospheric pressure plasma treatment may reduce risk of transmitting norovirus

Treating surfaces with cold atmospheric pressure plasma (CAPP) may reduce the risk of transmitting norovirus, a contagious virus leading to stomach pain, nausea and diarrhea, according to a new study.

14 Jan 2015

Ebola epidemic in Liberia could be eliminated by June, finds study

The Ebola epidemic in Liberia could likely be eliminated by June if the current high rate of hospitalization and vigilance can be maintained, according to a new model developed by ecologists at the University of Georgia and Pennsylvania State University.

13 Jan 2015

Obstetric care during Ebola epidemic are deeply challenging

Obstetric interventions during an Ebola epidemic are deeply challenging say two new commentaries published today (14 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

13 Jan 2015

Disease/Infection News

Study unveils genetic architecture that enables parasite to develop antimalarial drug resistance

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

UC RUSAL announces opening of new epidemic and microbiological research centre in Guinea

Increase in Lassa fever cases could be due to human-to-human transmission, research reveals

Early estimates indicate flu vaccine is providing little protection in US

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

Mobile diagnosis device to help reduce unnecessary antibiotics prescribing

Leading microbiologist warns of killer fungi’s increasing threat

New computer model could predict responses to disease outbreak

NIAID awards contracts to support early-stage human clinical trials of infectious disease treatments

HIV/AIDS survival rates lower in the southern U.S.

People with iron overload disease are more vulnerable to Vibrio vulnificus infections

Study suggests that antibiotics may help fight norovirus

Universal vaccine against flu may be on the horizon, say researchers

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

Mayo Clinic expert explains difference between severe sepsis and septic shock

QDREC software may help find effective treatment for schistosomiasis

Cold atmospheric pressure plasma treatment may reduce risk of transmitting norovirus

Ebola epidemic in Liberia could be eliminated by June, finds study

Obstetric care during Ebola epidemic are deeply challenging

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News